Home/ Stocks/ VANI

Vivani Medical, Inc. Common Stock (DE)

VANI XNAS

$1.12 -0.02 (-1.69%) ▼ 15-min delayed

Open

$1.17

High

$1.17

Low

$1.12

Volume

149.8K

Market Cap

$95.82M

About Vivani Medical, Inc. Common Stock (DE)

Vivani Medical Inc is a clinical-stage biopharmaceutical company whose primary focus is the development of miniature subdermal drug implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases with once or twice-yearly administration. Its flagship drug implant candidates are designed to improve medication adherence and provide smooth, consistent therapeutic levels of GLP-1, the same class of active pharmaceutical ingredients used in Ozempic, Trulicity, and Wegovy.

Sector: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Employees: 36 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-6,530,000	$-0.11
Q1 2025	$0	$-6,302,000	$-0.11
FY 2024	$0	$-23,486,000	$-0.43
Q3 2024	$0	$-6,041,000	$-0.11

Earnings & Analyst Ratings

Next Earnings: Mon, May 11, 2026

Calendar →

Related Market News

No specific coverage for VANI yet. Check out our latest market news or earnings calendar.

Get VANI Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Vivani Medical, Inc. Common Stock (DE).

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.